These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3619161)

  • 41. Massive theophylline overdose. Rapid elimination by charcoal hemoperfusion.
    Ehlers SM; Zaske DE; Sawchuk RJ
    JAMA; 1978 Aug; 240(5):474-5. PubMed ID: 96282
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Influence of activated charcoal on the pharmacokinetics of moxifloxacin following intravenous and oral administration of a 400 mg single dose to healthy males.
    Stass H; Kubitza D; Möller JG; Delesen H
    Br J Clin Pharmacol; 2005 May; 59(5):536-41. PubMed ID: 15842551
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Repeated dosage of activated charcoal--an effective treatment in theophylline poisoning].
    Nellgård P; Heath A
    Lakartidningen; 1988 Jan; 85(4):219-20. PubMed ID: 3352408
    [No Abstract]   [Full Text] [Related]  

  • 44. Severe theophylline poisoning: charcoal haemoperfusion or haemodialysis?
    Higgins RM; Hearing S; Goldsmith DJ; Keevil B; Venning MC; Ackrill P
    Postgrad Med J; 1995 Apr; 71(834):224-6. PubMed ID: 7784283
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Oral activated charcoal to enhance theophylline elimination in an acute overdose.
    Gal P; Miller A; McCue JD
    JAMA; 1984 Jun; 251(23):3130-1. PubMed ID: 6726987
    [No Abstract]   [Full Text] [Related]  

  • 46. Kinetics of intravenous theophylline.
    Chrzanowski FA; Niebergall PJ; Mayock RL; Taubin JM; Sugita ET
    Clin Pharmacol Ther; 1977 Aug; 22(2):188-95. PubMed ID: 884920
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Repetitive doses of activated charcoal in the treatment of poisoning.
    Jones J; McMullen MJ; Dougherty J; Cannon L
    Am J Emerg Med; 1987 Jul; 5(4):305-11. PubMed ID: 3297081
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Severe theophylline intoxication: a delay in charcoal haemoperfusion solved by oral activated charcoal.
    Rutten J; van den Berg B; van Gelder T; van Saase J
    Nephrol Dial Transplant; 2005 Dec; 20(12):2868-9. PubMed ID: 16115857
    [No Abstract]   [Full Text] [Related]  

  • 49. Activated charcoal alone and followed by whole-bowel irrigation in preventing the absorption of sustained-release drugs.
    Lapatto-Reiniluoto O; Kivistö KT; Neuvonen PJ
    Clin Pharmacol Ther; 2001 Sep; 70(3):255-60. PubMed ID: 11557913
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of repeated doses of oral activated charcoal in the treatment of acute intoxications.
    McLuckie A; Forbes AM; Ilett KF
    Anaesth Intensive Care; 1990 Aug; 18(3):375-84. PubMed ID: 2221332
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Theophylline absorption by effervescent activated charcoal (Medicoal).
    Helliwell M; Berry D
    J Int Med Res; 1981; 9(3):222-5. PubMed ID: 7238997
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevention of drug absorption in simulated theophylline overdose.
    Minton NA; Glucksman E; Henry JA
    Hum Exp Toxicol; 1995 Feb; 14(2):170-4. PubMed ID: 7779441
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Severe theophylline toxicity. Role of conservative measures, antiarrhythmic agents, and charcoal hemoperfusion.
    Greenberg A; Piraino BH; Kroboth PD; Weiss J
    Am J Med; 1984 May; 76(5):854-60. PubMed ID: 6720731
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment of theophylline poisoning with haemoperfusion.
    Lynn KL; Buttimore AL; Begg EJ; Gordon GS
    N Z Med J; 1988 Jan; 101(838):4-5. PubMed ID: 3380419
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Potential pharmacodynamic effect of charcoal on theophylline neurotoxicity in normal rats.
    Hoffman A
    Pharmacol Biochem Behav; 1992 Oct; 43(2):621-3. PubMed ID: 1438500
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of dialysis in the management and prevention of theophylline toxicity. Commentary.
    Weinberger M; Hendeles L
    Dev Pharmacol Ther; 1980; 1(1):26-30. PubMed ID: 7438965
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multiple-dose activated charcoal: a review of relevant clinical studies.
    Bradberry SM; Vale JA
    J Toxicol Clin Toxicol; 1995; 33(5):407-16. PubMed ID: 7650765
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effectiveness of multiple-dose activated charcoal in lamotrigine poisoning: a case series.
    Hatanaka K; Kamijo Y; Kitamoto T; Hanazawa T; Yoshizawa T; Ochiai H; Haga Y
    Clin Toxicol (Phila); 2022 Mar; 60(3):379-381. PubMed ID: 34405740
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Theophylline intoxication: clinical features and pharmacokinetics during treatment with charcoal hemoperfusion.
    Shechter P; Berkenstat H; Segal E; Rapoport J
    Isr J Med Sci; 1996 Sep; 32(9):766-70. PubMed ID: 8865834
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacokinetics of theophylline and bioavailability of a sustained release theophylline preparation in patients with cystic fibrosis.
    Valet SB; Schwartz RH; Brooks JG
    Ann Allergy; 1983 Mar; 50(3):161-5. PubMed ID: 6829982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.